HBRM - Herborium Group Inc - Page 3

HBRM Sweet Chart:http://investorshub.advfn.com/boards...ge_id=50794634

Good morning subscribers. This morning we are still buzzing over Herborium Group Inc., HBRM.PK. The company is gaining traction in the market place with investors. We had one question. Do their products work? Well, we did some digging to find out what the reviews were saying. What we found out was that they do work. AcnEase is their flagship product so we are bringing you reviews of it this morning. Read on and make up your own mind to the efficacy of the product.

The company is stepping into the acne arena armed with a product that effectively treats the diseased area without the use of a topical treatment. No creams or ointments to apply multiple times daily.

The market for OTC acne treatments alone was projected to pass the 550 million dollar mark by the year 2008. This dollar amount reperesents nearly 17% of the OTC medicated skin care market.

http://www.majormarketprofiles.com/r...d=26585&s=snap


As a population, the USA has the largest percentage of overweight teens and young adults, those most likely to contract acne through poor diet alone.

As you can see, the market demand for AcnEase, coupled with the fact it really works, makes for an easy entry for Herborium Group to step onto the center stage as a leading provider for over the counter skin care treatment.

http://www.aragonproducts.com/thepro...fm?master=7566

The science behind AcnEase. AcnEase is a proprietary herbal acne treatment that was developed based on principles of Traditional Chinese Medicine and modern herbaceutical and pharmacological science. This all natural product is formulated with a Patented and Trade Secret protected blend of the highest quality herbal extracts.

The ability of AcnEase to serve as a natural acne treatment and to provide a natural acne cure is assured by extensive testing and strictly controlled manufacturing conditions. The ratio of the ingredients, the selection of herbs and the method of extraction are key factors in assuring the efficacy of AcnEase as a premium natural acne treatment.

Benefits: This unique acne treatment works in several ways: AcnEase prevents the forming of new pimples, whiteheads and blackheads and significantly improves symptoms associated with Adult Acne, Cystic Acne, Teen Acne and Body Acne.

AcnEase also reduces facial flushing and the incidence of blepheritis (itchy gritty eyes) and gastric reflux (heartburn), symptoms often associated with Rosacea.

http://www.onlineacneinfo.org/acne-p...cnease-review/

Get Rid of Acne from the Inside Out with AcnEase

While there are many products out there that are supposed to treat the acne problem, unfortunately not all of them are effective. In fact, some acne treatments actually end up doing more harm than good to your skin. For this reason, more and more people are beginning to turn to some of the natural acne treatments that are available. One excellent natural treatment out there that has proven to be very effective at treating acne is the product AcnEase. There are a variety of reasons that this products is definitely one of the best.

The Acne Problem is Properly Addressed

One of the reasons that AcnEase is such a great acne product is because it actually properly addresses the acne problem. There are many different products out there that only deal with treating the symptoms of acne; however, AcnEase actually works to get to the bottom of the problem. Instead of treating acne topically, this product treats the acne from the inside out and actually helps to balance out the body on the inside so that acne is no longer a problem that has to be dealt with. Although it can take a couple weeks to start showing results, the results are usually long lasting.


AcnEase Review

Acne problems are worse. They do not only damage your skin, but spoils your life as well. Several products have been sold in the market to treat this problem; but nothing came as close as AcnEase in treating acne infection. Find out more about this product by reading the review below.

http://hubpages.com/hub/acnease-review





Micro Cap Reports

http://www.microcapreports.com

June 2nd, 2010

Wednesday, June 02, 2010 8:59:56 AM

Good morning subscribers. This morning we are still buzzing over Herborium Group Inc., HBRM.PK. The company is gaining traction in the market place with investors. We had one question. Do their products work? Well, we did some digging to find out what the reviews were saying. What we found out was that they do work. AcnEase is their flagship product so we are bringing you reviews of it this morning. Read on and make up your own mind to the efficacy of the product.

The company is stepping into the acne arena armed with a product that effectively treats the diseased area without the use of a topical treatment. No creams or ointments to apply multiple times daily.

The market for OTC acne treatments alone was projected to pass the 550 million dollar mark by the year 2008. This dollar amount reperesents nearly 17% of the OTC medicated skin care market.

http://www.majormarketprofiles.com/r...d=26585&s=snap


As a population, the USA has the largest percentage of overweight teens and young adults, those most likely to contract acne through poor diet alone.

As you can see, the market demand for AcnEase, coupled with the fact it really works, makes for an easy entry for Herborium Group to step onto the center stage as a leading provider for over the counter skin care treatment.

http://www.aragonproducts.com/thepro...fm?master=7566

The science behind AcnEase. AcnEase is a proprietary herbal acne treatment that was developed based on principles of Traditional Chinese Medicine and modern herbaceutical and pharmacological science. This all natural product is formulated with a Patented and Trade Secret protected blend of the highest quality herbal extracts.

The ability of AcnEase to serve as a natural acne treatment and to provide a natural acne cure is assured by extensive testing and strictly controlled manufacturing conditions. The ratio of the ingredients, the selection of herbs and the method of extraction are key factors in assuring the efficacy of AcnEase as a premium natural acne treatment.

Benefits: This unique acne treatment works in several ways: AcnEase prevents the forming of new pimples, whiteheads and blackheads and significantly improves symptoms associated with Adult Acne, Cystic Acne, Teen Acne and Body Acne.

AcnEase also reduces facial flushing and the incidence of blepheritis (itchy gritty eyes) and gastric reflux (heartburn), symptoms often associated with Rosacea.

http://www.onlineacneinfo.org/acne-p...cnease-review/

Get Rid of Acne from the Inside Out with AcnEase

While there are many products out there that are supposed to treat the acne problem, unfortunately not all of them are effective. In fact, some acne treatments actually end up doing more harm than good to your skin. For this reason, more and more people are beginning to turn to some of the natural acne treatments that are available. One excellent natural treatment out there that has proven to be very effective at treating acne is the product AcnEase. There are a variety of reasons that this products is definitely one of the best.

The Acne Problem is Properly Addressed

One of the reasons that AcnEase is such a great acne product is because it actually properly addresses the acne problem. There are many different products out there that only deal with treating the symptoms of acne; however, AcnEase actually works to get to the bottom of the problem. Instead of treating acne topically, this product treats the acne from the inside out and actually helps to balance out the body on the inside so that acne is no longer a problem that has to be dealt with. Although it can take a couple weeks to start showing results, the results are usually long lasting.


AcnEase Review

Acne problems are worse. They do not only damage your skin, but spoils your life as well. Several products have been sold in the market to treat this problem; but nothing came as close as AcnEase in treating acne infection. Find out more about this product by reading the review below.

http://hubpages.com/hub/acnease-review





Micro Cap Reports

http://www.microcapreports.com

June 2nd, 2010

AH NEWS: Herborium Group Commences AcnEase(R) Retail Sales
AcnEase(R) Now Available in New York Dermatology Clinics

SADDLE BROOK, NJ, Jun 02, 2010 (MARKETWIRE via COMTEX) -- Herborium Group, Inc., (PINKSHEETS: HBRM), a Botanical Therapeutics(TM) company, today announced it has now successfully secured direct consumer points-of-sale for its flagship product, AcnEase(R), with a recognized group of New York dermatological clinics.

"Acceptance of AcnEase by board certified dermatologist to be sold in the clinics is a major third-party validation of the therapeutic value of our product, and is an important cornerstone in building the AcnEase(R) brand," commented Dr. Agnes P. Olszewski, Herborium Group's president and chief executive officer.

AcnEase(R) is a proprietary, all herbal, systemically acting botanical therapeutic targeting acne symptom in both females and males of all ages, and has been proven safe and effective through clinical testing. Test results have demonstrated that in adolescent acne, approximately 95% of patients responded positively to AcnEase. In individuals above age 31, the level of effectiveness was 80%. The overall positive response rate to AcnEase was 91%. After more than five years of online sales, Herborium has consistently registered over 95% consumer satisfaction rating (www.acnease.com).

Dr. Olszewski continued, "Expanding beyond e-commerce (internet sales) to direct consumer points-of-sale is an important milestone in our overall plan to increase AcnEase sales and brand recognition and grow market share within the US 3.5 billion over the counter medicated skin care market

"With the current surge in sales of over-the-counter nutritional and health supplements, combined with Hoffmann-La Roche Inc.'s announcement to discontinue marketing of its leading treatment for severe acne, Accutane(R) (isotretinoin), and Herborium's AcnEase product's demonstrated and documented over five year history of safe and effective acne treatment, I firmly believe we have the right product, at the right time, for over 50 million acne sufferers in the USA.

"Having successfully launched our direct-to-consumer sales strategy with AcnEase in the US market , we intend to replicate this strategy to the extent justified "by market conditions" in International markets, while we prepare our next product sales initiative to access the US cosmeceutical market expected to potentially reach over $16 billion by 2010.

"Herborium is committed to continue developing a global brand with a strong international distribution network, and the acceptance of AcnEase by the dermatological community is a key development in both product branding and sales growth strategies," Dr. Olszewski concluded.

About Herborium Group, Inc.

Herborium Group, Inc., a botanical therapeutics(R) company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium harvests its therapeutic candidates from Traditional Chinese Medicine and utilizes Western regulatory, clinical and marketing strategies to successfully introduce the products to the Western markets. The company secured a pipeline of botanical ingredients based products in the areas of dermatological needs, Prostate Health (BPH), Liver Diseases, Women's Health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, surgical procedures, and other problems. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.

One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends." We cannot promise future returns. Our statements reflect our best judgment at the time they are issued, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. Adino Energy Corporation urges investors to review the risks and uncertainties contained within its filings with the Securities and Exchange Commission.


Company Contact:
Dr. Agnes P. Olszewski
President & CEO
(201) 647-3757






SOURCE: Herborium Group, Inc.

Thursday, June 03, 2010 8:37:42 AM

Good morning investors. We are still buzzing about Herborium Group Inc., HBRM.PK. The company released tremendous news at the bell on Wednesday that announced to the public that they had acquired direct point of sale sites in dermatological clinics in the New York City area.

http://finance.yahoo.com/news/Herbor....html?x=0&.v=1

HBRM.PK traded up yesteray closing the day at $.0275, a gain of nearly 6% on heavy volume of 2.7 million shares. That sent the company to it's fourth day of higher closes day over day. This trend looks to continue with the news released at the bell yesterday.

http://stockcharts.com/h-sc/ui?s=hbrm

The flagship product for Herborium Group Inc. is AcnEase®, a clinically tested and proven effective over the counter acne treatment for people of all ages that are afflicted with acne.

AcnEase® is a proprietary, all herbal, systemically acting botanical therapeutic targeting acne symptom in both females and males of all ages, and has been proven safe and effective through clinical testing. Test results have demonstrated that in adolescent acne, approximately 95% of patients responded positively to AcnEase. In individuals above age 31, the level of effectiveness was 80%. The overall positive response rate to AcnEase was 91%. After more than five years of online sales, Herborium has consistently registered over 95% consumer satisfaction rating.

http://www.acnease.com

http://www.aragonproducts.com/thepro...fm?master=7566

http://www.onlineacneinfo.org/acne-p...cnease-review/

http://hubpages.com/hub/acnease-review

http://www.herborium.com/Investor_Relations.html

As you can see, AcnEase® has been tested for over 5 years and has proven to be a safe, over the counter alternative to the Hoffman-LaRouche product, Accutane, which will soon no longer be marketed by the pharmaceutical giant.

With clinical trials comes the need for management to oversee them. The company's leadership team has over 100 years experience in the pharmaceutical, bio tech and drug manufacturing indutries.

Dr. Agnes P. Olszewski Ph.D, MBA. Founder & CEO - 20+ years experience in business strategy and global marketing with private and public companies

Dr. James P. Gilligan Ph.D. Co-Founder & COO - 25+ years experience in biotechnology, drug development, manufacturing, clinical testing

Dr. Alhua Qi, MD and TCM/MD, VP Traditional Chinese Medicine - 30 years TCM drug development clinical practice, originator of acne and liver formulas.

John E. Donahue, Controller/SEC Advisor - 25+ years experience corporate finance, M&A, public accounting

Lawrence Woo, Director; Asia Business Advisor - Past President Pfizer Greater China , President Wyeth Pharmaceutical China


The staff at Micro Cap Reports likes what we see so far and will continue to bring you the most up to date and comprehensive coverage of Herborium Group Inc. as soon as news becomes available.

Micro Cap Reports

http://www.microcapreports.com

Investor Clueso Subsribers,

We LOVED the AH news on HBRM yesterday! HBRM: Successfully secured direct consumer points-of-sale for its flagship product, AcnEase®.

The stock is trading very nicely with steady accumulation. With a relatively small float for the price, we believe HBRM has tremendous potential. Volume is always key in trading any stock and HBRM is definately attracting significant volume these days.

HBRM Share Structure:
May 7th, 2010
O/S 147,470,708
FLOAT 41,960.487
RESTRICTED 105,510,221

Herborium Group Commences AcnEase(R) Retail Sales
AcnEase(R) Now Available in New York Dermatology Clinics
Jun 2, 2010 3:00:00 PM

Herborium Group, Inc., (HBRM), a Botanical Therapeutics? company, today announced it has now successfully secured direct consumer points-of-sale for its flagship product, AcnEase®, with a recognized group of New York dermatological clinics.

"Acceptance of AcnEase by board certified dermatologist to be sold in the clinics is a major third-party validation of the therapeutic value of our product, and is an important cornerstone in building the AcnEase® brand," commented Dr. Agnes P. Olszewski, Herborium Group's president and chief executive officer.

AcnEase® is a proprietary, all herbal, systemically acting botanical therapeutic targeting acne symptom in both females and males of all ages, and has been proven safe and effective through clinical testing. Test results have demonstrated that in adolescent acne, approximately 95% of patients responded positively to AcnEase. In individuals above age 31, the level of effectiveness was 80%. The overall positive response rate to AcnEase was 91%. After more than five years of online sales, Herborium has consistently registered over 95% consumer satisfaction rating (www.acnease.com).

Dr. Olszewski continued, "Expanding beyond e-commerce (internet sales) to direct consumer points-of-sale is an important milestone in our overall plan to increase AcnEase sales and brand recognition and grow market share within the US 3.5 billion over the counter medicated skin care market

"With the current surge in sales of over-the-counter nutritional and health supplements, combined with Hoffmann-La Roche Inc.'s announcement to discontinue marketing of its leading treatment for severe acne, Accutane® (isotretinoin), and Herborium's AcnEase product's demonstrated and documented over five year history of safe and effective acne treatment, I firmly believe we have the right product, at the right time, for over 50 million acne sufferers in the USA.

"Having successfully launched our direct-to-consumer sales strategy with AcnEase in the US market , we intend to replicate this strategy to the extent justified "by market conditions" in International markets, while we prepare our next product sales initiative to access the US cosmeceutical market expected to potentially reach over $16 billion by 2010.

"Herborium is committed to continue developing a global brand with a strong international distribution network, and the acceptance of AcnEase by the dermatological community is a key development in both product branding and sales growth strategies," Dr. Olszewski concluded.

About Herborium Group, Inc.

Herborium Group, Inc., a botanical therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium harvests its therapeutic candidates from Traditional Chinese Medicine and utilizes Western regulatory, clinical and marketing strategies to successfully introduce the products to the Western markets. The company secured a pipeline of botanical ingredients based products in the areas of dermatological needs, Prostate Health (BPH), Liver Diseases,
Women's Health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, surgical procedures, and other problems. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.

One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends." We cannot promise future returns. Our statements reflect our best judgment at the time they are issued, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events.

Company Contact:
Dr. Agnes P. Olszewski
President & CEO
(201) 647-3757 (201) 647-3757

Good morning HBRM! Off to a running start today, volume over 600K at green at 0.028!! Still time to load up before she explodes even further IMO

NEWS OUT ON HBRM

Herborium Group Commences AcnEase(R) Retail Sales

SADDLE BROOK, NJ -- (Marketwire)
06/02/10
Herborium Group, Inc., (PINKSHEETS: HBRM), a Botanical Therapeutics™ company, today announced it has now successfully secured direct consumer points-of-sale for its flagship product, AcnEase®, with a recognized group of New York dermatological clinics.

"Acceptance of AcnEase by board certified dermatologist to be sold in the clinics is a major third-party validation of the therapeutic value of our product, and is an important cornerstone in building the AcnEase® brand," commented Dr. Agnes P. Olszewski, Herborium Group's president and chief executive officer.

AcnEase® is a proprietary, all herbal, systemically acting botanical therapeutic targeting acne symptom in both females and males of all ages, and has been proven safe and effective through clinical testing. Test results have demonstrated that in adolescent acne, approximately 95% of patients responded positively to AcnEase. In individuals above age 31, the level of effectiveness was 80%. The overall positive response rate to AcnEase was 91%. After more than five years of online sales, Herborium has consistently registered over 95% consumer satisfaction rating (www.acnease.com).

Dr. Olszewski continued, "Expanding beyond e-commerce (internet sales) to direct consumer points-of-sale is an important milestone in our overall plan to increase AcnEase sales and brand recognition and grow market share within the US 3.5 billion over the counter medicated skin care market

"With the current surge in sales of over-the-counter nutritional and health supplements, combined with Hoffmann-La Roche Inc.'s announcement to discontinue marketing of its leading treatment for severe acne, Accutane® (isotretinoin), and Herborium's AcnEase product's demonstrated and documented over five year history of safe and effective acne treatment, I firmly believe we have the right product, at the right time, for over 50 million acne sufferers in the USA.

"Having successfully launched our direct-to-consumer sales strategy with AcnEase in the US market , we intend to replicate this strategy to the extent justified "by market conditions" in International markets, while we prepare our next product sales initiative to access the US cosmeceutical market expected to potentially reach over $16 billion by 2010.

"Herborium is committed to continue developing a global brand with a strong international distribution network, and the acceptance of AcnEase by the dermatological community is a key development in both product branding and sales growth strategies," Dr. Olszewski concluded.

HBRM volume is well in the millions again( currently 1,200,000), for the fifth day in a row.

http://ih.advfn.com/p.php?pid=historical&symbol=HBRM

Herborium Group, Inc., (PINKSHEETS: HBRM), a Botanical Therapeutics(TM) company, today announced it has now successfully secured direct consumer points-of-sale for its flagship product, AcnEase(R), with a recognized group of New York dermatological clinics.
"Acceptance of AcnEase by board certified dermatologist to be sold in the clinics is a major third-party validation of the therapeutic value of our product, and is an important cornerstone in building the AcnEase(R) brand," commented Dr. Agnes P. Olszewski, Herborium Group's president and chief executive officer.

AcnEase(R) is a proprietary, all herbal, systemically acting botanical therapeutic targeting acne symptom in both females and males of all ages, and has been proven safe and effective through clinical testing. Test results have demonstrated that in adolescent acne, approximately 95% of patients responded positively to AcnEase. In individuals above age 31, the level of effectiveness was 80%. The overall positive response rate to AcnEase was 91%. After more than five years of online sales, Herborium has consistently registered over 95% consumer satisfaction rating (www.acnease.com).

Dr. Olszewski continued, "Expanding beyond e-commerce (internet sales) to direct consumer points-of-sale is an important milestone in our overall plan to increase AcnEase sales and brand recognition and grow market share within the US 3.5 billion over the counter medicated skin care market

"With the current surge in sales of over-the-counter nutritional and health supplements, combined with Hoffmann-La Roche Inc.'s announcement to discontinue marketing of its leading treatment for severe acne, Accutane(R) (isotretinoin), and Herborium's AcnEase product's demonstrated and documented over five year history of safe and effective acne treatment, I firmly believe we have the right product, at the right time, for over 50 million acne sufferers in the USA.

"Having successfully launched our direct-to-consumer sales strategy with AcnEase in the US market , we intend to replicate this strategy to the extent justified "by market conditions" in International markets, while we prepare our next product sales initiative to access the US cosmeceutical market expected to potentially reach over $16 billion by 2010.

"Herborium is committed to continue developing a global brand with a strong international distribution network, and the acceptance of AcnEase by the dermatological community is a key development in both product branding and sales growth strategies," Dr. Olszewski concluded.

About Herborium Group, Inc.

Herborium Group, Inc., a botanical therapeutics(R) company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium harvests its therapeutic candidates from Traditional Chinese Medicine and utilizes Western regulatory, clinical and marketing strategies to successfully introduce the products to the Western markets. The company secured a pipeline of botanical ingredients based products in the areas of dermatological needs, Prostate Health (BPH), Liver Diseases, Women's Health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, surgical procedures, and other problems. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.

One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends." We cannot promise future returns. Our statements reflect our best judgment at the time they are issued, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. Adino Energy Corporation urges investors to review the risks and uncertainties contained within its filings with the Securities and Exchange Commission.

Friday, June 04, 2010 9:24:06 AM
HBRM:
Good morning investors and traders. Second verse, same as the first. We are still focusing on Herborium Group Inc., HBRM.PK this morning.

The technicals on this company all point to it trading above $.03 for the first time ever. That could happen as soon as this morning.

http://stockcharts.com/h-sc/ui?s=hbrm

The stock is still in the accumulation mode with 70% of the daily volume as buys. The stock closed May 26th at $.013 on very low volume.

Since that close we have had 5 consecutive sessions averaging 2 million shares daily and closed yesterday at $.0275. This trend is likely to continue into today's trading session as the momentun is still building on this company.

The company is still putting out great news releases to their shareholders as the CEO has committed to keep the company as transparent as possible while still growing the brands and
identity of the company.

This has such long term potential and it is one of the reasons we have this in our portfolio as a long term "hold".

Please read the links below for recent news and shareholder updates:

http://finance.yahoo.com/news/Herbor....html?x=0&.v=1

http://finance.yahoo.com/news/Herbor....html?x=0&.v=1

http://finance.yahoo.com/news/Herbor....html?x=0&.v=1

Herborium offers a robust business model designed to capitalize on the changing landscape in the healthcare sector spearheaded by novel regulatory, market and technological trends, and the cost advantage of natural medicinal products. Herborium’s unique blend of management’s expertise, clinical and regulatory know how in the US, Europe and PRC, diversified proprietary Botanical Therapeutics® portfolio and innovative marketing strategies provide for high-value, high-return opportunity and a strong entry barrier for potential competitors

great time to buy in if you haven't already

definitely check out HBRM if you haven't already

Thanks! I love the slot machine.

Tuesday, June 08, 2010 8:56:56 AM

Good morning subscriber's. This morning we want to alert you again to Herborium Group, Inc. HBRM.PK.

The company is quietly becoming a favorite for micro cap investors as they have been accumulating stock in this company in anticipation of news releases that will allow this stock to run. When the stock does run, and we feel this is going to take place this week, it should test the $.03 mark and cross over it with ease.

The volume has been steady, with an average of 2 million shares traded daily over the last 7 sessions. The chart shows that a bullish pattern is emerging on HBRM.PK. The 5 day MA is over the 13 day MA with the CMF, or Chaikin Money FLow showing an increase of 50% since June 1st.

This signals buy, buy, buy. The bullish trend is but one reason to invest in and trade in this company. Their line of products is another. Herborium Group packs this one two punch like few micro cap companies.

A solid product suite, a strong, low float stock with solid management committed to shareholder success.

We own it and think you should as well.


http://stockcharts.com/h-sc/ui?s=hbrm



Why Herborium Group:


Herborium Group is going to be a player in the botanical healing market.They are quietly staking their claim in this burgeoning 250 billion dollar world wide sector.



We want to refresh your memory as it relates to HBRM.PK


Herborium Group, Inc., is a novel botanical therapeutics® company focused on developing, licensing, and marketing of proprietary, botanical based medicinal products, targeting unmet medical needs. The Company responds to both consumers and healthcare professionals demand for safe, efficacious, all natural medicinal options for treatment and prevention of selected diseases and health concerns.


The Company business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The potential for this market assesses for over $125 Billion in the USA and UK alone.


http://www.herborium.com/indexalt.html


http://finance.yahoo.com/news/Herbor....html?x=0&.v=1


http://finance.yahoo.com/news/Herbor....html?x=0&.v=1



File Msg | Remove Msg | *Private* Reply

Herborium Group, Inc., is a novel botanical therapeutics® company focused on developing, licensing, and marketing of proprietary, botanical based medicinal products, targeting unmet medical needs. The Company responds to both consumers and healthcare professionals demand for safe, efficacious, all natural medicinal options for treatment and prevention of selected diseases and health

HBRM - Looking nice.

Hello Traders,

Herbal medicines currently account for one of the fastest growing markets in U.S. pharmacies and constitute a multi-billion dollar industry. Keeping in mind Herborium's new products that they are working on, not to mention the herbal remedies that they already have on the market, I think this stock is getting ready to start heading up!

HBRM - Herborium Group, Inc.

Herborium is working on several additions to its Product Portfolio. The near term products under development and consideration include:

The Liver Activator Series® - Complimentary Liver Support Products that target liver damage resulting from Hepatitis C, Hepatitis B, and Cirrhosis and focus on regaining liver wellness compromised by alcohol, drugs and environmental factors.
ProstAid - an all natural product focused on Benign Prostate Hyperplasia (BPH) and ProstCare a similar product that targets Prostatitis
CardioVitae® - a proprietary, fermentation based product using a Lucidium derived cell line targeting cardio-pulmonary insufficiencies. An enriched extract derived from a Ganoderma lucidium cell line that helps improve and accelerate recovery from cerebrovascular strokes is also under consideration.

Check out their website at http://www.Herborium.com

Best Regards,

StockCents

Herborium Group Names Dr. Harold Mermelshein MD to Its Scientific Advisory Board
SADDLE BROOK, NJ, Jun 15, 2010 (MARKETWIRE via COMTEX) -- Herborium Group, Inc. (PINKSHEETS: HBRM), a Botanical Therapeutics(TM) company, today announced the appointment of Dr. Harold Mermelshein, MD, a renowned New York dermatologist, to Herborium's Scientific Advisory Board.

"I'm pleased that such a prestigious dermatologist as Dr. Mermelshein has agreed to serve on our Scientific Advisory Board," commented Dr. Agnes P. Olszewski, Herborium Group's president and chief executive officer. "Dr. Mermelshein's career spans more than 30 years, during which time he has distinguished himself as a dedicated, learned advocate in dermatological academia, research, and clinical practice as well as pioneer in using complementary, scientifically based, alternative treatment modalities in clinical practice."

Dr. Mermelshein is Board Certified by, and a standing member of, the American Academy of Dermatology. A magna cum laude alumnus of New York Medical College. Dr. Mermelshein has served as Chief of Residency for New York University Medical Center's Skin and Cancer Unit and, since 1988, as the Associate Clinical Professor of the Center Dermatology Department.

Dr. Olszewski continued, "With Herborium's flagship product, AcnEase(R), now available through an increasing number of distribution channels in the US and abroad, we are focusing on strengthening its consumer and professional brand recognition. Dr. Mermelshein will play a key role in meeting and maintaining only the highest standards expected by medical professionals and consumers, further strengthening Herborium's differential brand advantage. To that end, he will advise management regarding the Company's proactive clinical validation and regulatory strategy speared the U.S. Food and Drug Administration's (FDA) guidance for the botanical drug product industry (FDA Guidance 2004)."

"With Herborium's business model based on clinical testing confirmation of our products efficacy, having Dr. Mermelshein among our team of medical experts will also facilitate further advancement of our clinical testing, and therefore strengthen a differential advantage and marketability of our products growing," concluded Dr. Olszewski.

About Herborium Group, Inc. Herborium Group, Inc., a botanical therapeutics(R) company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium harvests its therapeutic candidates from Traditional Chinese Medicine and utilizes Western regulatory, clinical and marketing strategies to successfully introduce the products to the Western markets. The company secured a pipeline of botanical ingredients based products in the areas of dermatological needs, Prostate Health (BPH), Liver Diseases, Women's Health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, surgical procedures, and other problems. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.

One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends." We cannot promise future returns. Our statements reflect our best judgment at the time they are issued, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. Adino Energy Corporation urges investors to review the risks and uncertainties contained within its filings with the Securities and Exchange Commission.


Company Contact:
Dr. Agnes P. Olszewski
President & CEO
(201) 647-3757